Gujarat Themis Board Approves Preferential Allotment to Raise ₹335 Crore
Gujarat Themis Biosyn Ltd · Outcome · 01 Sept 2026, 10:30 pm
Gujarat Themis Board Approves Preferential Allotment to Raise ₹335 Crore Gujarat Themis Biosyn's board on 1st Sep'26 approved a preferential allotment to raise ₹335 crore. The company will issue up to 82.11 lakh equity shares at ₹408 per share. The promoter group, Pharmaceutical Business Group (India) Limited, will be allotted 61.27 lakh shares, infusing ₹250 crore. The remaining shares will be allotted to four non-promoter investors, including India Special Assets Fund III and ISAF III Onshore Fund. The issue is subject to shareholder and regulatory approvals.
Original exchange filing (PDF)
More announcements from Gujarat Themis Biosyn Ltd
- Recording of Analysts Meet held on 16.11.2026 · 17 Nov 2026
- Please refer to the attached Analysts Presentation · 16 Nov 2026
- Please refer to the attachment · 16 Nov 2026
- Please refer to the intimation of resignation of Company Secretary & Compliance Officer. · 15 Nov 2026
- Please refer to the attachment · 14 Nov 2026
- Kindly refer to the Un-audited Standalone & Consolidated Financial Results for the quarter and half year ended 30.09.2026 · 14 Nov 2026
- Gujarat Themis Biosyn Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- Outcome of the Board Meeting held on 14.11.2026 · 14 Nov 2026
